Altimmune Inc (NAS:ALT)
$ 8.57 -0.16 (-1.83%) Market Cap: 609.54 Mil Enterprise Value: 471.93 Mil PE Ratio: 0 PB Ratio: 4.57 GF Score: 30/100

Q4 2020 Altimmune Inc Earnings Call Transcript

Feb 25, 2021 / 01:30PM GMT
Release Date Price: $17.2 (-12.16%)
Operator

Greetings, and welcome to the Altimmune Year-End 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host for today's call, Ms. Stacey Jurchison, Senior Director of Investor Relations and Corporate Communications at Altimmune. Stacey, you may begin.

Stacey Jurchison

Thank you, operator, and good morning, everyone. Thank you for participating in Altimmune's Year-End 2020 Earnings Conference Call. Leading the call today will be Vipin Garg, our Chief Executive Officer. Additional members of the Altimmune executive team participating on the call today are Will Brown, our Chief Financial Officer; Scot Roberts, our Chief Scientific Officer; and Scott Harris, our Chief Medical Officer. Following their prepared remarks, we will hold a question-and-answer session.

A press release with our year-end 2020 financial results was issued this morning and can be found on the IR section of the company's website.

Before we begin, I'd like to remind everyone that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot